Nonalcoholic fatty liver disease (NAFLD), characterized by hepatocyte dysfunction, fat accumulation, and fibrosis, is the most common cause of chronic liver disease in children. Elevated levels of serum alanine aminotransferase (ALT) are used clinically to identify potential liver dysfunction. Our goal was to assess for changes in the national prevalence of elevated ALT over time and potential relationship to trends in the metabolic syndrome (MetS) severity and elevated body mass index (BMI).
Materials and Methods:
We studied 5411 non-Hispanic white, non-Hispanic black, and Hispanic adolescents aged 12–19 with complete MetS Z-score and ALT data from the National Health and Nutrition Examination Survey 1999–2014. Elevated ALT levels were defined by two different cutoffs: one for both sexes (30 U/L) and another that was sex specific (22 U/L girls; 25 U/L boys). MetS severity was assessed using a sex- and race-/ethnicity-specific MetS Z-score.
Results:
We did not find a statistically significant linear increase in either mean ALT or the prevalence of elevated ALT differed over time. As expected, ALT levels were significantly correlated with BMI Z-score and MetS Z-score (P < 0.0001). Over time, BMI Z-scores increased and MetS severity Z-score decreased.
Conclusion:
Prevalence of elevated ALT did not exhibit a linear change between 1999 and 2014 in U.S. adolescents, potentially due to divergent trends regarding BMI and MetS severity. Continued vigilance in monitoring BMI and ALT levels is advised for the U.S. adolescent population. MetS Z-score could act as an additional tool to monitor risk of elevated ALT and subsequent development of NAFLD.
SchwimmerJB, BehlingC, NewburyR, et al.Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology, 2005; 42:641–649.
3.
FeldsteinAE, CharatcharoenwitthayaP, TreeprasertsukS, et al.The natural history of non-alcoholic fatty liver disease in children: A follow-up study for up to 20 years. Gut, 2009; 58:1538–1544.
4.
SchwimmerJB, PardeePE, LavineJE, et al.Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation, 2008; 118:277–283.
5.
AndersonEL, HoweLD, JonesHE, et al.The prevalence of non-alcoholic fatty liver disease in children and adolescents: A systematic review and meta-analysis. PLoS One, 2015; 10:e0140908.
6.
MachadoMV, Cortez-PintoH. Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. J Hepatol, 2013; 58:1007–1019.
7.
FraserA, LongneckerMP, LawlorDA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999–2004. Gastroenterology, 2007; 133:1814–1820.
8.
SchwimmerJB, NewtonKP, AwaiHI, et al.Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected nonalcoholic fatty liver disease. Aliment Pharmacol Therapeut, 2013; 38:1267–1277.
9.
BerkeyCS, RockettHRH, WillettWC, et al.Milk, dairy fat, dietary calcium, and weight gain —a longitudinal study of adolescents. Arch Pediatr Adolesc Med, 2005; 159:543–550.
10.
AdamsLA, SandersonS, LindorKD, et al.The histological course of nonalcoholic fatty liver disease: A longitudinal study of 103 patients with sequential liver biopsies. J Hepatol, 2005; 42:132–138.
11.
SanyalAJ, BruntEM, KleinerDE, et al.Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology, 2011; 54:344–353.
12.
VermaS, JensenD, HartJ, et al.Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Liver Int, 2013; 33:1398–1405.
13.
MiddletonJP, WienerRC, BarnesBH, et al.Clinical features of pediatric nonalcoholic fatty liver disease: A need for increased awareness and a consensus for screening. Clin Pediatr (Phila), 2014; 53:1318–1325.
14.
BarlowSE. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: Summary report. Pediatrics, 2007; 120:S164–S192.
15.
ChanDF, LiAM, ChuWC, et al.Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord, 2004; 28:1257–1263.
16.
FranzeseA, VajroP, ArgenzianoA, et al.Liver involvement in obese children—ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci, 1997; 42:1428–1432.
17.
PorterSA, PedleyA, MassaroJM, et al.Aminotransferase levels are associated with cardiometabolic risk above and beyond visceral fat and insulin resistance: The Framingham Heart Study. Arterioscler Thromb Vasc Biol, 2013; 33:139–146.
18.
SchwimmerJB, DeutschR, RauchJB, et al.Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr, 2003; 143:500–505.
19.
SchwimmerJB, DunnW, NormanGJ, et al.SAFETY study: Alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology, 2010; 138:1357–1364.
20.
TazawaY, NoguchiH, NishinomiyaF, et al.Serum alanine aminotransferase activity in obese children. Acta Paediatr, 1997; 86:238–241.
21.
SchwimmerJB, DeutschR, KahenT, et al.Prevalence of fatty liver in children and adolescents. Pediatrics, 2006; 118:1388–1393.
22.
DeboerMD, WienerRC, BarnesBH, et al.Ethnic differences in the link between insulin resistance and elevated ALT. Pediatrics, 2013; 132:e718–e726.
23.
NadeauKJ, KlingensmithG, ZeitlerP. Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. J Pediatr Gastroenterol Nutr, 2005; 41:94–98.
24.
DonnellyKL, SmithCI, SchwarzenbergSJ, et al.Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest, 2005; 115:1343–1351.
25.
LeeAM, GurkaMJ, DeBoerMD. Trends in metabolic syndrome severity and lifestyle factors among adolescents. Pediatrics, 2016; 137:1–9.
26.
StraussRS, BarlowSE, DietzWH. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr, 2000; 136:727–733.
27.
GurkaMJ, IceCL, SunSS, et al.A confirmatory factor analysis of the metabolic syndrome in adolescents: An examination of sex and racial/ethnic differences. Cardiovasc Diabetol, 2012; 11:128.
28.
GurkaMJ, LillyCL, NormanOM, et al.An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: A confirmatory factor analysis and a resulting continuous severity score. Metabolism, 2014; 63:218–225.
29.
GrahamRC, BurkeA, StettlerN. Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents. J Pediatr Gastroenterol Nutr, 2009; 49:442–449.
30.
DeBoerMD. Underdiagnosis of metabolic syndrome in non-hispanic black adolescents: A call for ethnic-specific criteria. Curr Cardiovasc Risk Rep, 2010; 4:302–310.
31.
DeBoerMD, GurkaMJ. Clinical utility of metabolic syndrome severity scores: Considerations for practitioners. Diabetes Metab Syndr Obes, 2017; 10:65–72.
32.
FordES, LiC, CookS, et al.Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation, 2007; 115:2526–2532.
33.
DeBoerMD, GurkaMJ. Ability among adolescents for the metabolic syndrome to predict elevations in factors associated with type 2 diabetes and cardiovascular disease: Data from the national health and nutrition examination survey 1999–2006. Metab Syndr Relat Disord, 2010; 8:343–353.
34.
FernandezJR, ReddenDT, PietrobelliA, et al.Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr, 2004; 145:439–444.
35.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics, 2004; 114:555–576.
36.
KliethermesS, MaM, PurtellC, et al.An assessment of racial differences in the upper limits of normal ALT levels in children and the effect of obesity on elevated values. Pediatr Obes, 2016 [Epub ahead of print]; DOI: 10.1111/ijpo.12152
37.
LouthanMV, TheriotJA, ZimmermanE, et al.Decreased prevalence of nonalcoholic fatty liver disease in black obese children. J Pediatr Gastroenterol Nutr, 2005; 41:426–429.
38.
U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2010. 7th Edition, Washington, DC: U.S. Government Printing Office, December2010.
39.
MesirowMS, WelshJA. Changing beverage consumption patterns have resulted in fewer liquid calories in the diets of US children: National Health and Nutrition Examination Survey 2001–2010. J Acad Nutr Diet, 2015; 115:559–566.e4.
40.
PiernasC, NgSW, PopkinB. Trends in purchases and intake of foods and beverages containing caloric and low-calorie sweeteners over the last decade in the United States. Pediatr Obes, 2013; 8:294–306.
41.
SchwimmerJB, McGrealN, DeutschR, et al.Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics, 2005; 115:e561–e565.
42.
SaadV, WicklowB, WittmeierK, et al.A clinically relevant method to screen for hepatic steatosis in overweight adolescents: A cross sectional study. BMC Pediatr, 2015; 15:151.
43.
MagerDR, MazurakV, Rodriguez-DimitrescuC, et al.A meal high in saturated fat evokes postprandial dyslipemia, hyperinsulinemia, and altered lipoprotein expression in obese children with and without nonalcoholic fatty liver disease. JPEN J Parenter Enteral Nutr, 2013; 37:517–528.
44.
LoprinziPD, SmitE, CardinalBJ, et al.Valid and invalid accelerometry data among children and adolescents: Comparison across demographic, behavioral, and biological variables. Am J Health Promot, 2014; 28:155–158.
45.
CollinsCE, WatsonJ, BurrowsT. Measuring dietary intake in children and adolescents in the context of overweight and obesity. Int J Obes (Lond), 2010; 34:1103–1115.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
